Reapplix, a Danish developer of a treatment for diabetic foot ulcers, has raised $20m in funding from investors including North-East Healthcare Investment, Lauxera Capital Partners and MK Ventures.
UCL Technology Fund closed on £50m in January 2016 and is now fully deployed
All five lawyers have joined from Clifford Chance and will focus on mandates for private equity firms
Deal is part of a buy-and-build strategy pursued by the GP to strengthen Italcanditi's market position
Tavola already owns Frische und Service's Swiss market peer Ceposa, which it acquired in 2018